United Kingdom (UK) Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: June 23, 2025 Report Code: GDME0619MDB-ST

Select Item

GlobalData’s “United Kingdom Drug Delivery Devices Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United Kingdom Drug Delivery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories – Infusion Systems, Central Venous Catheters and Implantable Ports

The United Kingdom Drug Delivery Devices Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
• 2023 company share and distribution share data for Drug Delivery Devices Market.
• Global corporate-level profiles of key companies operating within the United Kingdom Drug Delivery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United Kingdom Drug Delivery Devices is segmented as follows –

• Infusion Systems

• Central Venous Catheters

• Implantable Ports

Reasons to Buy

The United Kingdom Drug Delivery Devices Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

B. Braun Melsungen AG_x000D_
Becton Dickinson and Co_x000D_
Teleflex Inc_x000D_
Baxter International Inc_x000D_
ICU Medical Inc_x000D_
Edwards Lifesciences Corp_x000D_
Vygon SA

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 6

2 Introduction 8

2.1 What Is This Report About? 8

2.2 Drug Delivery Devices Market Segmentation 8

2.3 Definitions of Markets Covered in the Report 9

3 Drug Delivery Devices Market, United Kingdom 11

3.1 Drug Delivery Devices Market, United Kingdom, Revenue ($m), 2018-2033 11

3.2 Drug Delivery Devices Market, United Kingdom, Revenue Mix ($m), 2023 12

3.3 Drug Delivery Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2023 13

3.4 Drug Delivery Devices Market, United Kingdom, Revenue ($m), 2018-2033 14

3.5 Drug Delivery Devices Market, United Kingdom, Volume (Units), 2018-2033 16

3.6 Drug Delivery Devices Market, United Kingdom, Volume (Units), 2018-2033 17

3.7 Drug Delivery Devices Market, United Kingdom, Company Share by Revenue ($m), 2023 19

4 Central Venous Catheters Market, United Kingdom 21

4.1 Central Venous Catheters Market, United Kingdom, Revenue Mix ($m), 2023 21

4.2 Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2023 22

4.3 Central Venous Catheters Market, United Kingdom, Revenue ($m), 2018-2033 23

4.4 Central Venous Catheters Market, United Kingdom, Volume (Units), 2018-2033 25

4.5 Central Venous Catheters Market, United Kingdom, Average Price ($) , 2018-2033 27

4.6 Central Venous Catheters Market, United Kingdom, Distribution Share by Revenue ($m), 2023 28

4.7 Central Venous Catheters Market, United Kingdom, Company Share by Revenue ($m), 2023 29

5 Implantable Ports Market, United Kingdom 31

5.1 Implantable Ports Market, United Kingdom, Revenue Mix ($m), 2023 31

5.2 Implantable Ports Market, United Kingdom, Segment Contribution (%), 2023 32

5.3 Implantable Ports Market, United Kingdom, Revenue ($m), 2018-2033 33

5.4 Implantable Ports Market, United Kingdom, Volume (Units), 2018-2033 35

5.5 Implantable Ports Market, United Kingdom, Average Price ($), 2018-2033 37

5.6 Implantable Ports Market, United Kingdom, Distribution Share by Revenue ($m), 2023 38

5.7 Implantable Ports Market, United Kingdom, Company Share by Revenue ($m), 2023 39

6 Infusion Systems Market, United Kingdom 40

6.1 Infusion Systems Market, United Kingdom, Revenue Mix ($m), 2023 40

6.2 Infusion Systems Market, United Kingdom, Segment Contribution (%), 2023 41

6.3 Infusion Systems Market, United Kingdom, Revenue ($m), 2018-2033 42

6.3.1 Infusion Pump Disposables Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 44

6.3.2 Infusion Pumps Market, United Kingdom, Revenue ($m), by Segment, 2018-2033 46

6.4 Infusion Systems Market, United Kingdom, Volume (Units), 2018-2033 48

6.4.1 Infusion Pump Disposables Market, United Kingdom, Volume (Units), by Segment, 2018-2033 50

6.4.2 Infusion Pumps Market, United Kingdom, Volume (Units), by Segment, 2018-2033 52

6.5 Infusion Systems Market, United Kingdom, Average Price ($) , 2018-2033 54

6.6 Infusion Systems Market, United Kingdom, Distribution Share by Revenue ($m), 2023 55

6.7 Infusion Systems Market, United Kingdom, Company Share by Revenue ($m), 2023 56

7 Overview of Key Companies in United Kingdom, Drug Delivery Devices Market 58

7.1 B. Braun Melsungen AG 58

7.1.1 Company Overview 58

7.2 Becton Dickinson and Co 58

7.2.1 Company Overview 58

7.3 Teleflex Inc 58

7.3.1 Company Overview 58

7.4 Vygon SA 58

7.4.1 Company Overview 58

7.5 Kimal plc 59

7.5.1 Company Overview 59

7.6 Edwards Lifesciences Corp 59

7.6.1 Company Overview 59

7.7 ICU Medical Inc 59

7.7.1 Company Overview 59

8 Drug Delivery Devices Market Pipeline Products 60

9 Financial Deals Landscape 68

9.1 Acquisition 68

9.1.1 Spectra Medical Devices Acquires XL Precision Technologies from Rubicon Partners Industries 68

9.1.2 Molex Asia Holdings Acquires Vectura Group from Vectura Fertin Pharma for Up to USD393 Million 70

9.2 Equity Offerings 71

9.2.1 Biodexa Pharmaceuticals Raises USD5 Million in Registered Direct Offering of American Depositary Shares 71

9.2.2 N4 Pharma Raises USD0.80 Million in Private Placement of Shares 73

9.2.3 Biodexa Pharma Raises USD7 Million Upon Exercise of Warrants 75

9.3 Merger 76

9.3.1 MedPharm Merges with Tergus Pharma 76

9.4 Partnerships 78

9.4.1 Nutriband Enters into Licensing Agreement with Macfarlan Smith 78

9.4.2 PharmaJet Enters into Agreement with Scancell 80

9.4.3 Arecor Therapeutics Enters into Co-Development Agreement with Medtronic Diabetes 81

9.4.4 N4 Pharma Enters into Agreement with SRI International 82

9.5 Venture Financing 83

9.5.1 NanoSyrinx Raises USD13.07 Million in Venture Financing 83

9.5.2 PhoreMost Secures USD12 Million in Series B Funding 85

9.5.3 Meltwind Secures USD13 Million in Venture Funding 87

9.5.4 Locate Bio Raises USD11.49 Million in Venture Financing 89

10 Recent Developments 90

10.1 Corporate Communications 90

10.1.1 Feb 18, 2025: AstraZeneca Announces Directorate Change 90

10.1.2 Jan 16, 2025: Niox Group Announces Board Changes 90

10.1.3 Dec 16, 2024: AstraZeneca Announces Directorate Change 91

10.1.4 Dec 16, 2024: AstraZeneca: Non-Executive Board Appointments 91

10.1.5 Oct 22, 2024: Scancell Appoints Dr Phil L'Huillier as CEO 91

10.1.6 Sep 09, 2024: N4 Pharma Announces Director Appointment 92

10.1.7 Sep 09, 2024: N4 Pharma Appoints Michael Palfreyman as Independent Non-Executive Director 93

10.2 Financial Announcements 93

10.2.1 Mar 17, 2025: Belite Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update 93

10.2.2 Nov 14, 2024: Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update 95

10.2.3 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024 95

10.3 Government and Public Interest 96

10.3.1 Aug 05, 2024: Antengene Announces XPOVIO (selinexor) Approved for Commercialization in Malaysia 96

10.4 Other Significant Developments 97

10.4.1 Jan 23, 2025: UK Biocentre Chooses Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence 97

10.4.2 Oct 16, 2024: Bespak Announces Closure of North Carolina site 98

10.4.3 Aug 22, 2024: Pharma Latch Signs Memorandum of Understanding with The Pandemic Institute 98

10.4.4 Jun 12, 2024: Scancell Signs Agreement with Major International Biotechnology Company to Evaluate an Antibody in the Glymab Portfolio 99

10.4.5 May 06, 2024: Kindeva Drug Delivery Invests in Second Manufacturing Line for Greener Inhalers at UK Manufacturing Site 99

10.5 Product News 100

10.5.1 Apr 15, 2025: Aurora Cannabis Introduces the Company's First Inhalable Resin Cartridges for Patients in the United Kingdom 100

10.5.2 Apr 02, 2025: Owen Mumford Announces Launch of UnifineOTC 100

10.5.3 Jun 25, 2024: Ayrton Saunders Announces Landmark UK MHRA Approval of Next Generation Nicotine Inhaler System for Rapid, Safe Relief of Nicotine Craving to Aid Smoking Cessation 101

10.5.4 May 22, 2024: Qinecsa Host Industry Discussion On Navigating Post-marketing Safety Surveillance Of Medical Devices And Drug-device Combination Products, Eu And Usa 101

10.5.5 May 21, 2024: PhoreMost Introduces GlueSEEKER Platform for Discovery of Molecular Glue Degraders 102

10.6 Strategy And Business Planning 102

10.6.1 Nov 07, 2024: BD and INS Partner to Elevate Standards of Infusion Care in MENAT 102

10.6.2 Aug 15, 2024: Hoth Therapeutics and Aronnax Enter Master Services Agreement For HT-KIT Cancer Therapeutic 103

10.6.3 Jun 04, 2024: Kindeva Drug Delivery Expands Loughborough, UK, Facilities at Charnwood Campus to Support Growth of Green Propellant Commercialization 103

10.6.4 May 07, 2024: Innovative Nanomedicine Company, Vianautis Is the Latest Biotech to Join the Impressive Line-up at Howard Group’s Prestigious Unity Campus 104

11 Appendix 105

11.1 Research Methodology 106

11.1.1 Coverage 106

11.1.2 Secondary Research 106

11.1.3 Primary Research 107

11.1.4 Market Modeling and Forecasting 108

11.1.5 Company Share Analysis 109

11.1.6 Distribution Share Analysis 109

11.1.7 Benchmarking 110

11.2 GlobalData Consulting 110

11.3 Contact Us 110

11.4 Disclaimer 111

Table

Table 1: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 11

Table 2: Drug Delivery Devices Market, United Kingdom, Category Contribution by Revenue ($m), 2023 13

Table 3: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 15

Table 4: Drug Delivery Devices Market, United Kingdom, Volume (Units), 2018-2033 16

Table 5: Drug Delivery Devices Market, United Kingdom, Volume (Units), 2018-2033 18

Table 6: Drug Delivery Devices Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 20

Table 7: Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2023 22

Table 8: Central Venous Catheters Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 24

Table 9: Central Venous Catheters Market, United Kingdom, Volume (Units), 2018-2033 26

Table 10: Central Venous Catheters Market, United Kingdom, Average Price ($), 2018-2033 27

Table 11: Central Venous Catheters Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023 28

Table 12: Central Venous Catheters Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 30

Table 13: Implantable Ports Market, United Kingdom, Segment Contribution (%), 2023 32

Table 14: Implantable Ports Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 34

Table 15: Implantable Ports Market, United Kingdom, Volume (Units), 2018-2033 36

Table 16: Implantable Ports Market, United Kingdom, Average Price ($), 2018-2033 37

Table 17: Implantable Ports Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023 38

Table 18: Implantable Ports Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 39

Table 19: Infusion Systems Market, United Kingdom, Segment Contribution (%), 2023 41

Table 20: Infusion Systems Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 43

Table 21: Infusion Pump Disposables Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 45

Table 22: Infusion Pumps Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 47

Table 23: Infusion Systems Market, United Kingdom, Volume (Units), 2018-2033 49

Table 24: Infusion Pump Disposables Market, United Kingdom, Volume (Units), 2018-2033 51

Table 25: Infusion Pumps Market, United Kingdom, Volume (Units), 2018-2033 53

Table 26: Infusion Systems Market, United Kingdom, Average Price ($), 2018-2033 54

Table 27: Infusion Systems Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2023 55

Table 28: Infusion Systems Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2023 57

Table 29: Drug Delivery Devices Market Pipeline Products 60

Table 30: Spectra Medical Devices Acquires XL Precision Technologies from Rubicon Partners Industries 68

Table 31: Molex Asia Holdings Acquires Vectura Group from Vectura Fertin Pharma for Up to USD393 Million 70

Table 32: Biodexa Pharmaceuticals Raises USD5 Million in Registered Direct Offering of American Depositary Shares 71

Table 33: N4 Pharma Raises USD0.80 Million in Private Placement of Shares 73

Table 34: Biodexa Pharma Raises USD7 Million Upon Exercise of Warrants 75

Table 35: MedPharm Merges with Tergus Pharma 76

Table 36: Nutriband Enters into Licensing Agreement with Macfarlan Smith 78

Table 37: PharmaJet Enters into Agreement with Scancell 80

Table 38: Arecor Therapeutics Enters into Co-Development Agreement with Medtronic Diabetes 81

Table 39: N4 Pharma Enters into Agreement with SRI International 82

Table 40: NanoSyrinx Raises USD13.07 Million in Venture Financing 83

Table 41: PhoreMost Secures USD12 Million in Series B Funding 85

Table 42: Meltwind Secures USD13 Million in Venture Funding 87

Table 43: Locate Bio Raises USD11.49 Million in Venture Financing 89

Table 44: Total Number of Primary Research Participants, Drug Delivery Devices Market, by Country 107

Figures

Figure 1: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 11

Figure 2: Drug Delivery Devices Market, United Kingdom, Revenue Mix ($m), 2023 12

Figure 3: Drug Delivery Devices Market, United Kingdom, Category Contribution (%), 2023 13

Figure 4: Drug Delivery Devices Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 14

Figure 5: Drug Delivery Devices Market, United Kingdom, Volume (Units), 2018-2033 16

Figure 6: Drug Delivery Devices Market, United Kingdom, Volume (Units), 2018-2033 17

Figure 7: Drug Delivery Devices Market, United Kingdom, Company Share (%) 2023 19

Figure 8: Central Venous Catheters Market, United Kingdom, Revenue Mix ($m), 2023 21

Figure 9: Central Venous Catheters Market, United Kingdom, Segment Contribution (%), 2023 22

Figure 10: Central Venous Catheters Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 23

Figure 11: Central Venous Catheters Market, United Kingdom, Volume (Units), 2018-2033 25

Figure 12: Central Venous Catheters Market, United Kingdom, Company Share (%) 2023 29

Figure 13: Implantable Ports Market, United Kingdom, Revenue Mix ($m), 2023 31

Figure 14: Implantable Ports Market, United Kingdom, Segment Contribution (%), 2023 32

Figure 15: Implantable Ports Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 33

Figure 16: Implantable Ports Market, United Kingdom, Volume (Units), 2018-2033 35

Figure 17: Implantable Ports Market, United Kingdom, Company Share (%) 2023 39

Figure 18: Infusion Systems Market, United Kingdom, Revenue Mix ($m), 2023 40

Figure 19: Infusion Systems Market, United Kingdom, Segment Contribution (%), 2023 41

Figure 20: Infusion Systems Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 42

Figure 21: Infusion Pump Disposables Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 44

Figure 22: Infusion Pumps Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033 46

Figure 23: Infusion Systems Market, United Kingdom, Volume (Units), 2018-2033 48

Figure 24: Infusion Pump Disposables Market, United Kingdom, Volume (Units), 2018-2033 50

Figure 25: Infusion Pumps Market, United Kingdom, Volume (Units), 2018-2033 52

Figure 26: Infusion Systems Market, United Kingdom, Company Share (%) 2023 56

United Kingdom (UK) Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Drug Delivery Devices reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United Kingdom (UK) Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems in real time.

  • Access a live United Kingdom (UK) Drug Delivery Devices Market Outlook to 2033: Central Venous Catheters , Implantable Ports and Infusion Systems dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more